Interestingly enough, in 6-OHDA rats, the dual GLP-1/GIP agonist (DA5-CH), in addition to promoting the survival of dopaminergic neurons, was able to reduce the levels of monomer and oligomers of -synuclein, thus providing a wider neuroprotective effect [53]
McGowan, M.D., Ph.D., Julio Rosenstock, M.D., Marie T.D
How do I avoid energy crashes on these medications
GLP-1 medications are not approved for treating alcohol use disorder, and any effects on drinking behaviour are incidental rather than therapeutic
Ask how your health is monitored while on these injections, how to help minimize common side effects, and about warning signs or any symptoms that require immediate medical attention